Elanco Animal Health Incorporated has grown revenue 5.1% a year over three years and 2.0% a year over five. Revenue growth, 3-year annual rate: +5.1% (Drug Manufacturers - Specialty & Generic median +13%). Revenue growth, 5-year rate: +2.0%, growth has picked up over the last three years. Years of annual history on file: 10, FY2016 to FY2025, as filed.

ELANElanco Animal Health Incorporated

Healthcare

$22.92+19% 1Y

$22.92

$18.5452 weeks$26.84

Is it growing?

Good

Revenue growing +12% year on year. That is the only one of 3 checks this filer's data supports, so take it as a single data point rather than a settled answer.

1 good, 2 without data

Revenue trend+12% in a yearSEC EDGAR · Jun 30, 2026

Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: +2% a year.

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

Revenue growth, 3 yearsmiddle of the market

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is ELAN growing?

Elanco Animal Health Incorporated has grown revenue 5.1% a year over three years and 2.0% a year over five.

+5.1%

Revenue growth, 3-year annual rate · Drug Manufacturers - Specialty & Generic median +13% · steady growth, ahead of inflation · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +2.0%
Revenue growth, 5-year rate · +5.1% over three · growth has picked up over the last three years
Years of annual history on file: 10
Years of annual history on file · FY2016 to FY2025, as filed

Details›